AGYS

Agilysys, Inc.

84
Fundamentals83/ 100
Valuation81/ 100
Upside potential71/ 100
Risk potential19/ 100

AGYS has the edge over ASTS overall, supported by stronger valuation and lower modeled downside.

ASTS

AST SpaceMobile, Inc.

49
Fundamentals66/ 100
Valuation50/ 100
Upside potential65/ 100
Risk potential46/ 100

ASTS trails on the overall score without a compensating advantage in the available component scores.

AGYS Fundamentals

MetricStatus
Healthy
Strong
Strong
Strong

AGYS's revenue, profitability, cash flow and balance sheet are all currently healthy.

ASTS Fundamentals

MetricStatus
Healthy
Weak
Weak
Unavailable

ASTS's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.

AGYS PE Valuation

CHEAPFAIREXPENSIVE74x148x223x297x
CHEAPFAIREXPENSIVE74x148x223x297x
LevelPEPriceVs current
Cheap34x$52.61-57%
Forward42x$122—
Current77x$122—
Fair133x$209+72%
Expensive214x$336+176%

Historical ranges are pointers, not guarantees.

AGYS's PE is in its fair range at 77x. If earnings grow as analysts expect, today's price would be 42x next year's earnings, in its cheap range.

ASTS PE Valuation

ASTS has no meaningful PE right now: it lost money over the past year.

AGYS Forward outlook

MetricOutlook
Strongly improving
Strong growth
Strong growth
Strongly improving
Limited
High

Analysts expect strong earnings and revenue growth for AGYS, with profitability improving.

ASTS Forward outlook

MetricOutlook
--
Losses growing
Strong growth
--
Limited
Low

Analysts expect ASTS's losses to grow, with revenue growing. However, they disagree widely on these estimates.

AGYS Risk to reward

ScenarioChangePrice
Upside+46%$177.33
Downside-19%$98.64

Calculated from the latest close: $121.59 on Nov 12.

AGYS has a better modeled risk to reward balance than ASTS, with more potential upside relative to its potential downside.

ASTS Risk to reward

ScenarioChangePrice
Upside+86%$64.16
Downside-46%$18.77

Calculated from the latest close: $34.50 on Nov 12.

ASTS trails AGYS on modeled risk to reward, with less potential upside relative to its potential downside.

AGYS Earnings Per Share

Q4 2023: $3.19Q1 2024: $3.17Q2 2024: $3.63Q3 2024: $3.52Q4 2024: $0.81Q1 2025: $0.82Q2 2025: $0.49Q3 2025: $0.85Q4 2025: $1.06Q1 2026: $1.37Q2 2026: $1.52Q3 2026: $1.57Forward: $2.91
Q4 2023: $3.19Q1 2024: $3.17Q2 2024: $3.63Q3 2024: $3.52Q4 2024: $0.81Q1 2025: $0.82Q2 2025: $0.49Q3 2025: $0.85Q4 2025: $1.06Q1 2026: $1.37Q2 2026: $1.52Q3 2026: $1.57Forward: $2.91
QuarterTTM EPSYoY
Forward$2.91+85%
Q3 2026$1.57+85%
Q2 2026$1.52+210%
Q1 2026$1.37+67%
Q4 2025$1.06+31%
Q3 2025$0.85-76%
Q2 2025$0.49-87%
Q1 2025$0.82-74%
Q4 2024$0.81-75%

AGYS has the edge over ASTS on earnings quality, reporting a profit while its opponent remains loss making.

ASTS Earnings Per Share

Q1 2024: $-0.98Q2 2024: $-1.25Q3 2024: $-2.12Q4 2024: $-1.95Q1 2025: $-1.99Q2 2025: $-1.89Q3 2025: $-1.24Q4 2025: $-1.34Q1 2026: $-1.80Q2 2026: $-2.16Q3 2026: $-2.15
Q1 2024: $-0.98Q2 2024: $-1.25Q3 2024: $-2.12Q4 2024: $-1.95Q1 2025: $-1.99Q2 2025: $-1.89Q3 2025: $-1.24Q4 2025: $-1.34Q1 2026: $-1.80Q2 2026: $-2.16Q3 2026: $-2.15
QuarterTTM EPSYoY
Q3 2026-$2.15-$0.91
Q2 2026-$2.16-$0.27
Q1 2026-$1.80+$0.19
Q4 2025-$1.34+$0.61
Q3 2025-$1.24+$0.88
Q2 2025-$1.89-$0.64
Q1 2025-$1.99-$1.01
Q4 2022-$0.58-$0.21

ASTS is still losing money, but far less than before: $2.15 per share over the past year, against $5.76 at its worst in mid-2021.

AGYS Quarterly Revenue

Q4 2023: $61MQ1 2024: $62MQ2 2024: $64MQ3 2024: $68MQ4 2024: $70MQ1 2025: $74MQ2 2025: $77MQ3 2025: $79MQ4 2025: $80MQ1 2026: $83MQ2 2026: $88MQ3 2026: $93M
Q4 2023: $61MQ1 2024: $62MQ2 2024: $64MQ3 2024: $68MQ4 2024: $70MQ1 2025: $74MQ2 2025: $77MQ3 2025: $79MQ4 2025: $80MQ1 2026: $83MQ2 2026: $88MQ3 2026: $93M
QuarterRevenueYoY
Q3 2026$93.4M+18%
Q2 2026$87.7M+14%
Q1 2026$82.9M+12%
Q4 2025$80.4M+16%
Q3 2025$79.3M+16%
Q2 2025$76.7M+21%
Q1 2025$74.3M+19%
Q4 2024$69.6M+15%

AGYS's revenue has grown year over year for 22 quarters in a row: $93M last quarter, up 18% from the same quarter a year ago.

ASTS Quarterly Revenue

Q4 2023: $0Q1 2024: $500,000Q2 2024: $900,000Q3 2024: $1MQ4 2024: $2MQ1 2025: $718,000Q2 2025: $1MQ3 2025: $15MQ4 2025: $54MQ1 2026: $15MQ2 2026: $32MQ3 2026: $42M
Q4 2023: $0Q1 2024: $500,000Q2 2024: $900,000Q3 2024: $1MQ4 2024: $2MQ1 2025: $718,000Q2 2025: $1MQ3 2025: $15MQ4 2025: $54MQ1 2026: $15MQ2 2026: $32MQ3 2026: $42M
QuarterRevenueYoY
Q3 2026$42.3M+187%
Q2 2026$31.5M+2627%
Q1 2026$14.7M+1952%
Q4 2025$54.3M+2731%
Q3 2025$14.7M+1240%
Q2 2025$1.2M+28%
Q1 2025$718K+44%
Q3 2022$4.2M+70%

ASTS's revenue has grown year over year for 11 quarters in a row: $42M last quarter, up 187% from the same quarter a year ago.

AGYS Free Cash Flow

Q4 2023: $11MQ1 2024: $29MQ2 2024: $229,000Q3 2024: $6MQ4 2024: $20MQ1 2025: $26MQ2 2025: −$5MQ3 2025: $15MQ4 2025: $23MQ1 2026: $35MQ2 2026: $7MQ3 2026: $15M
Q4 2023: $11MQ1 2024: $29MQ2 2024: $229,000Q3 2024: $6MQ4 2024: $20MQ1 2025: $26MQ2 2025: −$5MQ3 2025: $15MQ4 2025: $23MQ1 2026: $35MQ2 2026: $7MQ3 2026: $15M
QuarterFree cash flowYoY
Q3 2026$14.8M-1.2%
Q2 2026$7.3M+$12.3M
Q1 2026$35.4M+34%
Q4 2025$22.7M+15%
Q3 2025$15M+153%
Q2 2025-$5M-2274%
Q1 2025$26.5M-9.8%
Q4 2024$19.7M+75%

AGYS has the edge over ASTS on cash generation, producing positive trailing cash flow while its opponent burns cash.

ASTS Free Cash Flow

Q4 2023: −$47MQ1 2024: −$88MQ2 2024: −$38MQ3 2024: −$64MQ4 2024: −$110MQ1 2025: −$149MQ2 2025: −$354MQ3 2025: −$303MQ4 2025: −$331MQ1 2026: −$310MQ2 2026: −$695MQ3 2026: −$464M
Q4 2023: −$47MQ1 2024: −$88MQ2 2024: −$38MQ3 2024: −$64MQ4 2024: −$110MQ1 2025: −$149MQ2 2025: −$354MQ3 2025: −$303MQ4 2025: −$331MQ1 2026: −$310MQ2 2026: −$695MQ3 2026: −$464M
QuarterFree cash flowYoY
Q3 2026-$464.2M-$161.4M
Q2 2026-$694.8M-$341.1M
Q1 2026-$309.7M-$160.7M
Q4 2025-$330.7M-$220.3M
Q3 2025-$302.9M-$239.1M
Q2 2025-$353.6M-$315.3M
Q1 2025-$149M-$61.3M
Q4 2024-$110.5M-$63.2M

ASTS has burned cash in almost every quarter: −$1.8B over the past year, against −$916M the year before.

AGYS Total Shares

Q4 2023: 27MQ1 2024: 27MQ2 2024: 28MQ3 2024: 28MQ4 2024: 28MQ1 2025: 28MQ2 2025: 28MQ3 2025: 28MQ4 2025: 28MQ1 2026: 28MQ2 2026: 28MQ3 2026: 29M
Q4 2023: 27MQ1 2024: 27MQ2 2024: 28MQ3 2024: 28MQ4 2024: 28MQ1 2025: 28MQ2 2025: 28MQ3 2025: 28MQ4 2025: 28MQ1 2026: 28MQ2 2026: 28MQ3 2026: 29M
PeriodChange %Net change
Quarterly+0.6%+157K shares
1 year+0.6%+180K shares
3 years+9.4%+2.5M shares
5 years+12%+3.2M shares
Available history+23%+5.3M shares

AGYS has the edge over ASTS on shareholder dilution, with a more favorable share count trend.

ASTS Total Shares

Q4 2023: 90MQ1 2024: 121MQ2 2024: 141MQ3 2024: 156MQ4 2024: 199MQ1 2025: 224MQ2 2025: 242MQ3 2025: 273MQ4 2025: 256MQ1 2026: 291MQ2 2026: 299MQ3 2026: 300M
Q4 2023: 90MQ1 2024: 121MQ2 2024: 141MQ3 2024: 156MQ4 2024: 199MQ1 2025: 224MQ2 2025: 242MQ3 2025: 273MQ4 2025: 256MQ1 2026: 291MQ2 2026: 299MQ3 2026: 300M
PeriodChange %Net change
Quarterly+0.4%+1.1M shares
1 year+10%+27.3M shares
3 years+235%+211M shares
5 years+480%+248M shares
Available history+944%+271M shares

ASTS has 300M diluted shares, up 10% from a year ago.

AGYS Net Leverage

Q4 2023: -5.6xQ1 2024: -6.9xQ2 2024: -5.6xQ3 2024: -0.2xQ4 2024: -0.8xQ1 2025: -1.6xQ2 2025: -1.4xQ3 2025: -1.5xQ4 2025: -1.8xQ1 2026: -2.2xQ2 2026: -2.2xQ3 2026: -2.4x
Q4 2023: -5.6xQ1 2024: -6.9xQ2 2024: -5.6xQ3 2024: -0.2xQ4 2024: -0.8xQ1 2025: -1.6xQ2 2025: -1.4xQ3 2025: -1.5xQ4 2025: -1.8xQ1 2026: -2.2xQ2 2026: -2.2xQ3 2026: -2.4x
QuarterNet LeverageStatus
Q3 2026-2.4xNet Cash
Q2 2026-2.2xNet Cash
Q1 2026-2.2xNet Cash
Q4 2025-1.8xNet Cash
Q3 2025-1.5xNet Cash
Q2 2025-1.4xNet Cash
Q1 2025-1.6xNet Cash
Q4 2024-0.8xNet Cash

AGYS has more cash than debt.

ASTS Net Leverage

ASTS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.

AGYS Weekly Momentum

MetricValueStatus
RSI63.4Neutral
Stochastic79.9Neutral

AGYS's weekly RSI is 63 (neutral) and its Stochastic is 80 (neutral).

ASTS Weekly Momentum

MetricValueStatus
RSI34.1Neutral
Stochastic11.9Oversold

ASTS's weekly RSI is 34 (neutral) and its Stochastic is 12 (oversold).

AGYS PE vs Technology Sector

MetricAGYSSector medianRelative
PE77x28x178% above
PE %37352 pts above

AGYS is trading at 77x earnings, a 178% premium to the Technology sector's median of 28x.

ASTS PE vs Technology Sector

ASTS has no meaningful PE right now: it lost money over the past year.

AGYS Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$111.68.9% above
20 week MA$109.711% above
50 week MA$96.925% above
100 week MA$99.922% above
200 week MA$93.929% above

AGYS has the edge over ASTS on trend strength, trading above more of its moving averages.

ASTS Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$44.923% below
20 week MA$57.140% below
50 week MA$75.554% below
100 week MA$57.840% below
200 week MA$33.62.8% above

ASTS has fallen below most of its moving averages, though it's still 2.8% above its 200-week average.

AGYS Yearly ROI

YearStart priceEnd priceROI
2020$25.5$41.0+61%
2021$41.0$44.4+8.3%
2022$44.4$80.1+80%
2023$80.1$84.8+5.9%
2024$84.8$135.6+60%
2025$135.6$121.5-10%
2026 YTD$121.5$121.6+0.1%

AGYS has the edge over ASTS on returns for 2026, with the stronger performance.

ASTS Yearly ROI

YearStart priceEnd priceROI
2020$9.87$13.4+36%
2021$13.4$8.71-35%
2022$8.71$3.97-54%
2023$3.97$6.03+52%
2024$6.03$22.9+280%
2025$22.9$72.0+214%
2026 YTD$72.0$34.5-52%

ASTS's yearly returns have swung widely, from +280% in 2024 to −54% in 2022. It's down 52% so far in 2026.

Give your agent the market.

Get API key